The 2024 Outlook For Global Pharma

2024 Pharm Exec Top 50 Companies

Amid the Pharma 50's continued makeover, a mini-resetting of sorts is also underway. While projections by Evaluate and others, not surprisingly, ...

2025 Outlook and Expectations for Global Pharma, Biotech

BI's global healthcare team will discuss issues, expectations and key events anticipated in 2024 for Pharma and Biotech.

Numerof's 2024 Outlooks for the Healthcare Sector

Numerof's 2024 Outlooks for the Healthcare Sector · The Numerof 2024 Global Pharma Outlook · The Numerof 2024 Global Medical Device Outlook · The Numerof 2024 US ...

Raises 2024 Financial Outlook including on Revenues, Adjusted ...

The International Markets segment includes more than 35 countries, covering a substantial portion of the global pharmaceutical industry. As part of a recent ...

AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US ...

AstraZeneca now expects high-teens percentage growth in 2024 revenue and core earnings per share, from a previous forecast of mid-teens ...

2024 outlook for Life Sciences & Pharmaceuticals - MHA

The government is proposing to increase the allowed growth rate for branded medicine sales to 2% per year, from the current 1.1%. The government ...

Future of Pharma – Looking Ahead to 2024 - GlobalData

Year Ahead Threats -looking ahead in 2024 using sales forecasts and clinical analyses to identify events and trends that may pose a threat.

Global Pharmaceutical Outlook and Implications of GLP-1 Drugs

Positive outlook drivers for the global pharmaceutical industry · Rising use of industry blockbusters including GLP-1 products · Exposure to ...

Active Pharmaceutical Ingredients: Global Markets - BCC Research

The market is projected to reach $347.9 billion in 2029, growing at a CAGR of 5.9% during the forecast period. What segments are covered in the market?

Bayer – Global Home | Bayer Global

Bayer: Strategic progress in challenging business environment – Group outlook ... read more. Last Updated: Tuesday, November 12, 2024. Our Business.

Pharmaceuticals Wholesale and Distribution Market Size 2024-2028

Global Pharmaceuticals Wholesale And Distribution size is estimated to ... Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table ...

Pharma outlook: From uncertainty to predictability - Norstella

Worldwide prescription drug sales are forecast to grow by almost 7.7% per year over the next five years, outpacing the previous five years and ...

Generative AI in the pharmaceutical industry - McKinsey & Company

The technology could offer pharma companies a once-in-a-century opportunity—but only if they learn to scale it and address the industry's unique ...

The rise and rise of the pharmaceutical supply chain in India - Maersk

Beyond just keeping up with the demand at home, the Indian pharma industry commands over 20% of the global pharma supply chain and addresses ...

2024 Global Healthcare Outlook – Institutional | BlackRock

Notably, healthcare's 12-month forward earnings growth is expected to lead all other sectors on a year on year basis, with year over year sales growth trailing ...

Life Sciences Highlights and 2024 Outlook - Dechert LLP

There is a growing emphasis on licensing and collaboration to advance innovative medicines. The effect of generative AI and machine learning on protein-based ...

FT Global Pharma and Biotech Summit 2024 - Carb-X

Advances in technology are transforming research and development. Innovative treatments such as mRNA vaccines and cell therapies are reshaping healthcare as we ...

Industry Trends Pharmaceuticals September 2024 - Atradius Australia

Looking ahead global pharmaceuticals output growth will remain robust, forecast to increase by 3% in 2024, 4% in 2025 and 3.6% in 2026.

Life Sciences: Trends & Outlook – April 2024 - Savills

The larger pharma companies are assessed on their future prospects, which is driven by their ownership and creation of intellectual property (IP).

Pharmaceuticals Market Size, Growth - Industry Forecast 2030

The Global Pharmaceuticals market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market. Companies are ...